REGISTERED COMPANY NUMBER: 07035369 (England and Wales) REGISTERED CHARITY NUMBER: 1133259
Report of the Trustees and
Unaudited Financial Statements for the Year Ended 30th September 2021
for
The British Dermatological Nursing Group
Chesterton Consultancy Ltd 42 Abbotsbury Gardens Pinner Middlesex HA5 1SX
The British Dermatological Nursing Group
Contents of the Financial Statements for the Year Ended 30th September 2021
| Page | |
|---|---|
| Report of the Trustees | 1 to 6 |
| Independent Examiner's Report | 7 |
| Statement of Financial Activities | 8 |
| Statement of Financial Position | 9 to 10 |
| Statement of Cash Flows | 11 |
| Notes to the Statement of Cash Flows | 12 |
| Notes to the Financial Statements | 13 to 20 |
| Detailed Statement of Financial Activities | 21 to 22 |
The British Dermatological Nursing Group
Report of the Trustees
for the Year Ended 30th September 2021
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 30th September 2021. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Objectives and aims
The unincorporated British Dermatological Nursing Group was formed in 1989 after recognising the need for a low cost educational platform to assist nurses in developing their skills and experience in dermatological nursing.
The Group has a Constitution that is reviewed on an annual basis to ensure that it reflects the changing needs of the members as well as that of the Charities Commission. Any amendments to the Constitution are voted in by the Group at the Annual General Meeting.
The Group has referred to the guidance in the Charity Commission's general guidance on Public Benefit when reviewing our aims and objectives and in planning our future activities and we believe that the activities we undertake are a clear benefit to the public and in accordance with the aims and objectives we have set.. In particular, the Trustees consider how planned activities will contribute to the aims and objectives they have set. Specifically, the objects of the Group are to preserve and protect health and relieve sickness by maintaining and improving standards of practice in dermatological nursing for the public benefit.
Strategies
Development of strategic aims for the group to:
-
Ensure the structure of the BDNG is appropriate for its purpose;
-
Ensure the BDNG maximises its influence and communicates to key stakeholders;
-
Develop sound financial plans and practices to ensure income is sufficient to meet expenditure;
-
Provide appropriate educational and practice development to members;
-
Ensure the BDNG website meets the needs of its members;
-
Ensure the BDNG meets the needs of its existing and future membership.
Through the development of sub groups, the Group continues to offer peer support and information sharing. These sub groups report directly to the Committee and the Chair of each of these groups is a co-opted member of the Committee.
The Group continues to have representation of various external groups from within the Committee and also identified Group members. These representatives report directly to the Committee.
Page 1
The British Dermatological Nursing Group
Report of the Trustees
for the Year Ended 30th September 2021
ACHIEVEMENT AND PERFORMANCE
Charitable activities
The year 2020-2021 continued to be affected by the Covid pandemic. Changing regulations and levels of Covid made it difficult to plan educational events and on more than one occasion planned activity had to be cancelled at the last minute. In some cases this lead to financial losses for the organisation. However, we continued to run a successful programme of virtual educational sessions and introduced podcasts to our range of educational materials. All of our education is supported by a newly developed app which facilitates access to resources and providing feedback.
We were also very pleased to be able to run our annual conference in September with an attendance of 317 delegates. High quality educational sessions were extremely well attended with delegates giving very positive feedback. We were well supported by our industry colleagues with an excellent exhibition hall. The celebrations of our 30th conference anniversary allowed everyone to relax with friends and colleagues after a very difficult year. As well as supporting members through educational events, we continue to support them financially offering awards to attend events and for supporting their own practice development. This year we offered 30 free places at conference to reflect our 30th anniversary. The specialist interests of members are represented through our subgroups which are free to join and who help the organisation to produce clinically relevant educational opportunities.
The ambassadors for the organisation continue to contribute and supported conference by acting as chairs for educational sessions. The educational nurse has worked with some of them to develop their skills in presenting and writing and their contribution to the organisation is very much valued.
The executive team (Trustees) provided support for the objectives of the BDNG responding to clinical and organisational queries, supporting educational events, assisting with the strategic development of the organisation and meeting regularly virtually. The Trustees also represent the organisation at a number of external committees including the All Party Parliamentary Group on Skin, Dermatology Council for England (a Trustee is the Chair) and the National Outpatient Transformation Programme. The BDNG continues to contribute to discussions around the Getting it Right First Time Report with particular reference to workforce planning. Carrie Wingfield, a long standing Trustee, decided to step down which has meant that there are currently six Trustees with plans to recruit new members by Conference 2022. The President and Chief Executive now have regular meetings with our counterparts at the British Association of Dermatologists.
Highlighting the role of the dermatology nurse nationally continues to feature in our work. June 2021 saw the publication of a supplement in the Guardian newspaper on skin health which featured an article publicising what dermatology nurses contribute to the care of people with skin conditions.
Dermatological Nursing, the official journal of the BDNG, continues to provide up to date relevant information and education for our members. As well as securing regular income through advertising, the journal has also attracted non-promotional sponsorship. There has been a focus throughout the year on articles related to research, these have been supported by virtual online sessions for members.
The Educational Development nurse has continued to focus on developing the educational content for all of our delivery platforms. She started work on developing an educational strategy for the organisation. She continued to support the work undertaken by the British Association of Dermatologists nursing workstreams group and the European Academy of Dermatology and Venereology nursing group.
Ongoing projects which continued to be developed in this year was the Fast Facts book on Advanced Dermatology Nursing, promotional videos for dermatological nursing and an overall strategy and educational strategy for BDNG.
Page 2
The British Dermatological Nursing Group
Report of the Trustees
for the Year Ended 30th September 2021
FINANCIAL REVIEW
Principal funding sources
During the period the charity received corporate sponsorship of £389,968 (2020 - £168,501). In addition it received conference related income of £179,890 (2020 - £nil), subscriptions of £33,282 (2020 - £33,186), meeting attendance fees of £nil (2020 - £13,373), investment income of £5 (2020 - £152) and other income of £nil (2020 - £9,992).
Investment policy and objectives
The constitution authorises the trustees to apply the assets and property of the Charity solely towards the promotion and purpose of The British Nursing Dermatological Group as laid down in the constitution.
Reserves policy
Any funds provided to the British Dermatological Nursing Group for a specific purpose are classed as a restricted reserve. Trustees are resolved to limit spending each year to an amount considered to balance the interest of the current and future beneficiaries of the Group's work.
The Trustees have established a general policy of retaining funds equivalent to 6 months of expenditure in order to protect the Group's core activities in the event of a shortfall in income. However, in light of the Covid pandemic the trustees felt it prudent to temporarily increase the charity's retained funds by a further 25% thus allowing for an amount equivalent to 9 months expenditure. Now that Covid is hopefully in abeyance the trustees plan to slowly revert back to the 6 month policy.
Unrestricted reserves at the balance sheet date totalled £469,207 (2020 - £328,733 and restricted reserves of £8,426 (2020 - £3,426).
Going concern
The trustees assess whether the use of going concern is appropriate i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the company to continue as a going concern.
The trustees make this assessment in respect of a period of one year from the date of the approval of the financial statements and have concluded that there are no material uncertainties about the charity's ability to continue.
Page 3
The British Dermatological Nursing Group
Report of the Trustees
for the Year Ended 30th September 2021
FUTURE PLANS
The pandemic has meant that our educational provision has diversified and as we move forward we shall continue to embrace the opportunities provided by offering both virtual and face to face educational opportunities. As Covid restrictions are lifted we will re-instate our full programme of regional study days. As the organisation grows we realise the need for greater strategic vision and to this end we will look to develop an educational strategy that will feed into our overall strategy. In order to support the delivery of the strategy along with the various other projects we are developing, we plan to employ a senior project/education manager alongside our educational nurse. In order to support the increasingly complex resources we offer the website will be reconfigured to make accessing resources more straight forward.
We are actively seeking funds for a number of projects including developing quick reference handbook for clinicians, promotional videos seeking to increase the profile of dermatology nurses and developing our own awards ceremony to be held separately to the annual conference.
The 31st Annual Conference will be held in Harrogate in September 2022. As with last year we will provide workshops throughout the 3 days as this was well evaluated. We will create extra space to allow for additional educational activity. In the past we have created two streams, fundamental and advanced. This year we plan to offer a greater variety of content and discontinue the two specific streams. We will continue to offer financial support for members to attend the conference.
The BDNG continues to look to work with other dermatology nurses globally. We will look for ways that we can allow nurses from overseas to access our resources and specifically continue to work with the Burma Skin care Initiative to support nurses and other health care professionals in Myanmar.
During the pandemic our two full time staff worked at home. We have re-evaluated the Charity's needs in terms of space and have found more cost effective and spacious office accommodation making both social distancing easier and providing greater storage and meeting space.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The British Dermatological Nursing Group was incorporated on 30th September 2009 and is established as a company limited by guarantee and registered as a charity with the Charity Commission. The affairs of the Group are governed by its Memorandum and Articles of Association and managed by a Board of Directors who are Trustees of the Charity. The liability of each member in the event of the Group being wound up is limited to a sum not exceeding £1.
The British Dermatological Nursing Group was originally formed in 1989 as an unincorporated charity (No. 1077252). This charity ceased activity on the 31st May 2010 and its assets, totalling £262,898 were transferred to the new incorporated charity as of that date under a Transfer of Assets resolution dated 21st April 2010.
The directors of the company are also charity trustees for the purposes of charity law and under the company's Articles are known as Committee Members of the Charity. At the Annual General Meeting a vote was taken to change the articles of association allowing executive committee members to serve for up to 5 years on the committee and for there to be a maximum of seven Committee Members. No Committee Member shall be eligible for re-election for a period of 12 months from the date that his or her office comes to an end.
Page 4
The British Dermatological Nursing Group
Report of the Trustees for the Year Ended 30th September 2021
STRUCTURE, GOVERNANCE AND MANAGEMENT
Recruitment and appointment of new trustees
It is the existing Trustees' responsibility to identify potential Trustees with appropriate skills and background from the Group's membership. Trustees are elected annually and reflect the national membership of the group. The Trustees are elected for a fixed term of office. Following this term, they retire from the position of Trustee.
Key management remuneration
The trustees consider the board of Trustees and the Operations Manager as comprising the key management personnel of the charity in charge of directing and controlling the charity, and running and operating the charity on a day to day basis. Trustees are responsible for the management of The British Dermatological Nursing Group for which they receive no remuneration. The remuneration of the Operations Manager is agreed by the Trustees when reviewing the previous year's annual accounts. The Operations Manager's remuneration is aligned to job roles and appropriate pay scales within both the private and NHS sectors.
Risk management
The BDNG has a comprehensive Risk Assessment Policy which categories the impact of the principal risks to the Group. The key risks are the continuance of both sufficient corporate sponsorship and the possible impact this could have on financial planning and management and the income generated with the annual conference event. Forthcoming events are planned in light of both of these sources of income. This is regularly discussed and monitored at Trustee Meetings which are attended by the Trustees and the Operations Manager.
Potential corporate sponsors are investigated and the Trustees would consider diversification in other activities and sources of income if required.
REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number
07035369 (England and Wales)
Registered Charity number
1133259
Registered office
Centre 162, First Floor Holburn Gate 330 High Holburn London WC1V 7QT
Trustees
C G Wingfield (resigned 1.7.21) R H Penzer-Hick L Moorhead S Copperwheat M Sutherland A Barea R L Skrine
Company Secretary
Mrs S Maguire
Page 5
The British Dermatological Nursing Group
Report of the Trustees
for the Year Ended 30th September 2021
REFERENCE AND ADMINISTRATIVE DETAILS Independent Examiner Chesterton Consultancy Ltd 42 Abbotsbury Gardens Pinner Middlesex HA5 1SX
Solicitors
B P Collins Collins House 32-38 Station Road Gerrards Cross Buckinghamshire SL9 8EL
Approved by order of the board of trustees on 13th May 2022 and signed on its behalf by:
R H Penzer-Hick - Trustee
Page 6
Independent Examiner's Report to the Trustees of The British Dermatological Nursing Group
Independent examiner's report to the trustees of The British Dermatological Nursing Group ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 30th September 2021.
Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
Independent examiner's statement
Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a registered member of F.C.M.A. which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
-
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Graham J Bolton F.C.M.A. Chesterton Consultancy Ltd 42 Abbotsbury Gardens Pinner Middlesex HA5 1SX
13th May 2022
Page 7
The British Dermatological Nursing Group
Statement of Financial Activities
for the Year Ended 30th September 2021
| 2021 Unrestricted Restricted Total fund funds funds Notes £ £ £ INCOME AND ENDOWMENTS FROM Charitable activities 3 Education - - - Annual Conference 179,890 - 179,890 Other charitable activities - 5,000 5,000 Corporate Sponsorship 305,118 84,850 389,968 Investment income 2 5 - 5 Other income 33,282 - 33,282 Total 518,295 89,850 608,145 EXPENDITURE ON Raising funds 4 53,784 - 53,784 Charitable activities 5 Education 38,853 84,850 123,703 Annual Conference 157,640 - 157,640 Journal 76,309 - 76,309 Awards 14,851 - 14,851 Other charitable activities 36,384 - 36,384 Other - - - Total 377,821 84,850 462,671 NET INCOME/(EXPENDITURE) 140,474 5,000 145,474 RECONCILIATION OF FUNDS Total funds brought forward 328,733 3,426 332,159 TOTAL FUNDS CARRIED FORWARD 469,207 8,426 477,633 |
2020 Total funds £ 13,373 - - 168,501 152 43,178 225,204 3,289 90,603 17,070 125,186 2,158 21,605 800 260,711 (35,507) 367,666 332,159 |
|---|---|
The notes form part of these financial statements
Page 8
The British Dermatological Nursing Group
Statement of Financial Position 30th September 2021
| Unrestricted Restricted fund funds Notes £ £ FIXED ASSETS Tangible assets 11 1,885 - CURRENT ASSETS Debtors 12 230,354 - Cash at bank 371,853 8,426 602,207 8,426 CREDITORS Amounts falling due within one year 13 (134,885) - NET CURRENT ASSETS 467,322 8,426 TOTAL ASSETS LESS CURRENT LIABILITIES 469,207 8,426 NET ASSETS 469,207 8,426 FUNDS 14 Unrestricted funds Restricted funds TOTAL FUNDS |
2021 Total funds £ 1,885 230,354 380,279 610,633 (134,885) 475,748 477,633 477,633 469,207 8,426 477,633 |
2020 Total funds £ 663 117,521 274,529 392,050 (60,554) 331,496 332,159 332,159 328,733 3,426 332,159 |
|---|---|---|
The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th September 2021.
The members have not required the company to obtain an audit of its financial statements for the year ended 30th September 2021 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
-
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
The notes form part of these financial statements
continued...
Page 9
The British Dermatological Nursing Group
Statement of Financial Position - continued
30th September 2021
These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.
The financial statements were approved by the Board of Trustees and authorised for issue on 13th May 2022 and were signed on its behalf by:
R H Penzer-Hick - Trustee
The notes form part of these financial statements
Page 10
The British Dermatological Nursing Group
Statement of Cash Flows
for the Year Ended 30th September 2021
| Notes Cash flows from operating activities Cash generated from operations 1 Net cash provided by/(used in) operating activities Cash flows from investing activities Purchase of tangible fixed assets Interest received Net cash used in investing activities Change in cash and cash equivalents in the reporting period Cash and cash equivalents at the beginning of the reporting period Cash and cash equivalents at the end of the reporting period |
2021 £ 107,669 107,669 (1,924) 5 (1,919) 105,750 274,529 380,279 |
2020 £ (30,524) (30,524) (884) 152 (732) (31,256) 305,785 274,529 |
|---|---|---|
The notes form part of these financial statements
Page 11
The British Dermatological Nursing Group
Notes to the Statement of Cash Flows for the Year Ended 30th September 2021
1. RECONCILIATION OF NET INCOME/(EXPENDITURE) TO NET CASH FLOW FROM OPERATING ACTIVITIES
| Net income/(expenditure) for the reporting period (as per the Statement of Financial Activities) Adjustments for: Depreciation charges Interest received Increase in debtors Increase in creditors Net cash provided by/(used in) operations |
2021 £ 145,474 702 (5) (112,834) 74,332 107,669 |
2020 £ (35,507) 221 (152) (34,175) 39,089 (30,524) |
|---|---|---|
- ANALYSIS OF CHANGES IN NET FUNDS
| At 1/10/20 | Cash flow | At 30/9/21 | |
|---|---|---|---|
| £ | £ | £ | |
| Net cash | |||
| Cash at bank | 274,529 | 105,750 | 380,279 |
| 274,529 | 105,750 | 380,279 | |
| Total | 274,529 | 105,750 | 380,279 |
The notes form part of these financial statements
Page 12
The British Dermatological Nursing Group
Notes to the Financial Statements for the Year Ended 30th September 2021
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Critical accounting judgements and key sources of estimation uncertainty
In the application of the charity's accounting policies, the trustees are required to make judgements, estimates and assumptions that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant.
The judgement that management has made in the process of applying the charity's accounting policies which has the most significant effect on the amounts recognised in the accounts is the allocation of support costs across activities.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Raising funds
Cost of generating funds comprise of those costs directly attributable to generating sponsorship income.
Charitable activities
Charitable activities include all expenditure incurred in the pursuance of the Group's objectives.
Governance costs
Governance costs comprise of all costs involving the public accountability of the charity and its compliance with regulation and good practice. These costs include costs related to the preparation of the financial statements and legal fees.
Taxation
The charity is exempt from corporation tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
continued...
Page 13
The British Dermatological Nursing Group
Notes to the Financial Statements - continued for the Year Ended 30th September 2021
1. ACCOUNTING POLICIES - continued
Fund accounting
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
| 2. INVESTMENT INCOME Deposit account interest Bank interest is accounted for upon receipt. 3. INCOME FROM CHARITABLE ACTIVITIES Activity Regional meetings Education Annual conference Annual Conference Corporate Sponsorship Other charitable activities Corporate Sponsorship Corporate Sponsorship Journal advertising Corporate Sponsorship 4. RAISING FUNDS Other trading activities Staff costs Support costs External fundraising costs Depreciation |
2021 £ 5 2021 £ - 179,890 5,000 332,941 57,027 574,858 2021 £ 12,585 7,552 33,546 101 53,784 |
2020 £ 152 2020 £ 13,373 - - 109,700 58,801 |
2020 £ 152 2020 £ 13,373 - - 109,700 58,801 |
2020 £ 152 |
|---|---|---|---|---|
| 181,874 | ||||
| 2020 £ 3,289 - - - |
||||
| 3,289 |
continued...
Page 14
The British Dermatological Nursing Group
Notes to the Financial Statements - continued for the Year Ended 30th September 2021
5. CHARITABLE ACTIVITIES COSTS
| Support Direct costs (see Costs note 6) £ £ Education 111,818 11,885 Annual Conference 109,423 48,217 Journal 52,968 23,341 Awards 10,307 4,544 Other charitable activities 22,627 13,757 307,143 101,744 6. SUPPORT COSTS Governance Management costs £ £ Education 10,994 891 Annual Conference 44,605 3,612 Journal 21,593 1,748 Awards 4,203 341 Other charitable activities 9,224 4,533 90,619 11,125 7. NET INCOME/(EXPENDITURE) Net income/(expenditure) is stated after charging/(crediting): 2021 £ Depreciation - owned assets 702 |
Totals £ 123,703 157,640 76,309 14,851 36,384 |
|---|---|
| 408,887 | |
| Totals £ 11,885 48,217 23,341 4,544 13,757 |
|
| 101,744 | |
| 2020 £ 221 |
8. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 30th September 2021 nor for the year ended 30th September 2020.
Page 15
continued...
The British Dermatological Nursing Group
Notes to the Financial Statements - continued for the Year Ended 30th September 2021
8. TRUSTEES' REMUNERATION AND BENEFITS - continued
Trustees' expenses
The trustees had expenses reimbursed totalling £3,508 (2020 - £3,149) in respect of travel and subsistence.
9. STAFF COSTS
| 9. | STAFF COSTS | ||||
|---|---|---|---|---|---|
| 2021 | 2020 | ||||
| £ | £ | ||||
| Wages and salaries | 113,497 | 97,969 | |||
| Social security costs | 8,086 | 5,916 | |||
| Other pension costs | 3,173 | 2,718 | |||
| 124,756 | 106,603 | ||||
| The average monthly number of employees during the year was as follows: | |||||
| 2021 | 2020 | ||||
| Administration | 3 | 3 | |||
| The number of employees whose employee benefits (excluding employer | pension | costs) exceede | |||
| £60,000 was: | |||||
| 2021 | 2020 | ||||
| £60,001 - £70,000 | 1 | - | |||
| 10. | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES | ||||
| Unrestricted | Restricted | Total | |||
| fund | funds | funds | |||
| £ | £ | £ | |||
| INCOME AND ENDOWMENTS FROM | |||||
| Charitable activities | |||||
| Education | 13,373 | - | 13,373 | ||
| Corporate Sponsorship | 168,501 | - | 168,501 | ||
| Investment income | 152 | - | 152 | ||
| Other income | 41,178 | 2,000 | 43,178 | ||
| Total | 223,204 | 2,000 | 225,204 | ||
| EXPENDITURE ON | |||||
| Raising funds | 3,289 | - | 3,289 | ||
| Charitable activities | |||||
| Education | 90,603 | - | 90,603 | ||
| Annual Conference | 17,070 | - | 17,070 |
The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:
Page 16
continued...
The British Dermatological Nursing Group
Notes to the Financial Statements - continued for the Year Ended 30th September 2021
| 10. | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued | |
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | |||
| fund | funds | funds | |||
| £ | £ | £ | |||
| Journal | 125,186 | - | 125,186 | ||
| Awards | 2,158 | - | 2,158 | ||
| Other charitable activities | 21,605 | - | 21,605 | ||
| Other | 800 | - | 800 | ||
| Total | 260,711 | - | 260,711 | ||
| NET INCOME/(EXPENDITURE) | (37,507) | 2,000 | (35,507) | ||
| RECONCILIATION OF FUNDS | |||||
| Total funds brought forward | 366,240 | 1,426 | 367,666 | ||
| TOTAL FUNDS CARRIED | |||||
| FORWARD | 328,733 | 3,426 | 332,159 | ||
| 11. | TANGIBLE FIXED ASSETS | ||||
| Computer | |||||
| equipment | |||||
| £ | |||||
| COST | |||||
| At 1st October 2020 | 6,504 | ||||
| Additions | 1,924 | ||||
| At 30th September 2021 | 8,428 | ||||
| DEPRECIATION | |||||
| At 1st October 2020 | 5,841 | ||||
| Charge for year | 702 | ||||
| At 30th September 2021 | 6,543 | ||||
| NET BOOK VALUE | |||||
| At 30th September 2021 | 1,885 | ||||
| At 30th September 2020 | 663 |
continued...
Page 17
The British Dermatological Nursing Group
| Notes to the Financial Statements- continued for the Year Ended 30th September 2021 12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Trade debtors Other debtors Prepayments 13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Trade creditors Social security and other taxes VAT Other creditors Accruals and deferred income 14. MOVEMENT IN FUNDS At 1/10/20 £ Unrestricted funds General fund 328,733 Restricted funds World Congress of Dermatology 3,426 TOTAL FUNDS 332,159 |
2021 £ 172,520 1,780 56,054 230,354 2021 £ 31,452 2,924 14,597 57,270 28,642 134,885 Net movement in funds £ 140,474 5,000 145,474 |
2020 £ 63,378 - 54,143 |
|---|---|---|
| 117,521 | ||
| 2020 £ 16,535 2,808 3,797 3,720 33,694 |
||
| 60,554 | ||
| At 30/9/21 £ 469,207 8,426 |
||
| 477,633 |
continued...
Page 18
The British Dermatological Nursing Group
Notes to the Financial Statements - continued for the Year Ended 30th September 2021
14. MOVEMENT IN FUNDS - continued
Net movement in funds, included in the above are as follows:
| Incoming resources £ Unrestricted funds General fund 518,295 Restricted funds World Congress of Dermatology 5,000 Dermatology Nursing Book 84,850 89,850 TOTAL FUNDS 608,145 Comparatives for movement in funds At 1/10/19 £ Unrestricted funds General fund 366,240 Restricted funds World Congress of Dermatology 1,426 TOTAL FUNDS 367,666 Comparative net movement in funds, included in the above are as follows: Incoming resources £ Unrestricted funds General fund 223,204 Restricted funds World Congress of Dermatology 2,000 TOTAL FUNDS 225,204 |
Resources Movement expended in funds £ £ (377,821) 140,474 - 5,000 (84,850) - (84,850) 5,000 (462,671) 145,474 Net movement At in funds 30/9/20 £ £ (37,507) 328,733 2,000 3,426 (35,507) 332,159 Resources Movement expended in funds £ £ (260,711) (37,507) - 2,000 (260,711) (35,507) |
|---|---|
continued...
Page 19
The British Dermatological Nursing Group
Notes to the Financial Statements - continued for the Year Ended 30th September 2021
15. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 30th September 2021.
Page 20
The British Dermatological Nursing Group
Detailed Statement of Financial Activities for the Year Ended 30th September 2021
| INCOME AND ENDOWMENTS Investment income Deposit account interest Charitable activities Regional meetings Annual conference Corporate Sponsorship Journal advertising Other income Members subscriptions Government grants Other income Total incoming resources EXPENDITURE Other trading activities Wages Social security Pensions Support costs External fundraising costs Computer equipment Charitable activities Wages Social security Pensions Other charitable activities Conference costs Journal costs Carried forward |
2021 £ 5 - 179,890 337,941 57,027 574,858 33,282 - - 33,282 608,145 11,405 864 316 7,552 33,546 101 53,784 51,183 3,364 1,446 85,850 98,825 48,878 289,546 |
2020 £ 152 13,373 - 109,700 58,801 |
|---|---|---|
| 181,874 33,186 7,992 2,000 |
||
| 43,178 | ||
| 225,204 3,041 168 80 - - - |
||
| 3,289 44,103 2,449 1,157 - - 63,039 110,748 |
This page does not form part of the statutory financial statements
Page 21
The British Dermatological Nursing Group
Detailed Statement of Financial Activities for the Year Ended 30th September 2021
| Charitable activities Brought forward Regional meetings Awards Other Donations Support costs Management Wages Social security Pensions Serviced office rent Insurance Telephone Postage and stationery Sundries Staff welfare Travel & subsistence - Staff Travel & subsistence - Trustee Travel & subsistence - Cmtee Training Bank charges Non recoverable VAT Website development Computer equipment Governance costs Wages Social security Pensions Accountancy and legal fees Total resources expended Net income/(expenditure) |
2021 £ 289,546 8,047 9,550 307,143 - 47,478 3,598 1,316 16,950 435 4,037 2,353 63 - 2,665 3,004 2,820 79 277 4,001 942 601 90,619 3,431 260 95 7,339 11,125 462,671 145,474 |
2020 £ 110,748 32,070 1,500 144,318 800 47,784 3,131 1,401 23,289 354 6,097 1,630 112 642 5,277 3,149 5,891 923 255 - 1,640 221 101,796 3,041 168 80 7,219 10,508 260,711 (35,507) |
|---|---|---|
This page does not form part of the statutory financial statements
Page 22